Regeneron Pharmaceuticals, Inc. (REGN)
773.94
-6.56
(-0.84%)
USD |
NASDAQ |
Dec 30, 16:00
774.42
+0.48
(+0.06%)
After-Hours: 20:00
Regeneron Pharmaceuticals Free Cash Flow: 3.881B for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Amgen, Inc. | 11.54B |
| Gilead Sciences, Inc. | 9.162B |
| Johnson & Johnson | 20.46B |
| Eli Lilly & Co. | 6.436B |
| Merck & Co., Inc. | 13.05B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.619B |
| Cash from Investing (Quarterly) | -402.90M |
| Cash from Financing (Quarterly) | -717.90M |
| Free Cash Flow Per Share (Quarterly) | 12.82 |
| Free Cash Flow to Equity (Quarterly) | 1.374B |
| Free Cash Flow to Firm (Quarterly) | 1.390B |
| Free Cash Flow Yield | 4.55% |